-
1Academic Journal
Πηγή: Госпитальная медицина: наука и практика. :54-64
Θεματικοί όροι: гемостаз, лабораторный контроль, тромбоэластограмма, 3. Good health
-
2Academic Journal
Συγγραφείς: M. S. Mendibaev, S. E. Rabotinsky, М. С. Мендибаев, С. Е. Работинский
Πηγή: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 20, № 1 (2023); 81-88 ; Вестник анестезиологии и реаниматологии; Том 20, № 1 (2023); 81-88 ; 2541-8653 ; 2078-5658
Θεματικοί όροι: экстракорпоральный контур, thromboelastogram, heparin resistance, anticoagulation, extracorporeal circuit, тромбоэластограмма, гепаринорезистентность, антикоагуляция
Περιγραφή αρχείου: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/758/613; Строков А. Г., Поз Я. Л. Антикоагуляция при заместительной почечной терапии: классические подходы и новые возможности // Вестн. трансплантологии и искусственных органов. – 2010. – Т. 12, № 4. – С. 80–85.; Akil A., Ziegeler S., Reichelt J. et al. Use of CytoSorb and ECMO in patients with severe pneumogenic sepsis // Thorac Cardiovasc Surg. – 2021. – Vol. 69, № 3. – P. 246–251. Doi:10.1055/s-0040-1708479.; Arepally G. M., Ortel T. L. Heparin-induced thrombocytopenia // Annu Rev Med. – 2010. – Vol. 61. – P. 77–90. Doi:10.1146/annurev.med.042808.171814.; Bai M., Zhou M., He L. et al. Citrate versus heparin anticoagulationfor continuous renal replacement therapy: an updated meta-analysis of RCTs // Intensive Care Med. – 2015. – Vol. 41, № 12. – P. 2098–110. Doi:10.1007/s00134-015-4099-0.; Baldwin I., Tan H. K., Bridge N. et al. A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration // Ren Fail. – 2000. – Vol. 22, № 3. – P. 297–306. Doi:10.1081/jdi-100100873.; Brouwer W. P., Duran S., Kuijper M. et al. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study // Crit Care. – 2019. – Vol. 23, № 1. – P. 317. Doi:10.1186/s13054-019-2588-1.; Brunner R., Madl C., Druml W. et al. Single-dose application of antithrombin III as alternative anticoagulation during extracorporeal therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis // Crit Care. – 2011. – Vol. 15 (Suppl 1). – P. 123. Doi:10.1186/cc9543.; Cruz D.N., Antonelli M., Fumagalli R. et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial // JAMA. – 2009. – Vol. 301, № 23. – P. 2445–2452. Doi:10.1001/jama.2009.856.; Davenport A., Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit // NDT Plus. – 2009. – Vol. 6. – P. 439–447. Doi:10.1093/ndtplus/sfp136.; Davenport A. What are the anticoagulation options for intermittent hemodialysis? // Nat Rev Nephrol. – 2011. – Vol. 7, № 9. – P. 499–508. Doi:10.1038/nrneph.2011.88.; Dellinger R. P., Bagshaw S. M., Antonelli M. et al. EUPHRATES trial investigators. Effect of targeted polymyxin b hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial // JAMA. – 2018. – Vol. 320, № 14. – P. 1455–1463. Doi:10.1001/jama.2018.14618.; du Cheyron D., Bouchet B., Bruel C. et al. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study // Crit Care. – 2006. – Vol. 10, № 2. – R45. Doi:10.1186/cc4853.; Eller T., Busse J., Dittrich M. et al. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests // Clin Chem Lab Med. – 2014. – Vol. 52, № 6. – P. 835–844. Doi:10.1515/cclm-2013-0936.; Gonano C., Sitzwohl C., Meitner E. et al. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis // Crit Care. – 2006. – Vol. 10, № 6. – P. R160. Doi:10.1186/cc5098.; Honore P. M., De Bels D., Redant S. et al. Inducible metabolic pathway for citrate metabolism in case of major liver dysfunction: fact or fiction? // Crit Care. – 2019. – Vol. 23, № 1. – P. 166. Doi:10.1186/s13054-019-2432-7.; James M. F., Roche A. M. Dose-response relationship between plasma ionized calcium concentration and thrombelastography // J Cardiothorac Vasc Anesth. – 2004. – Vol. 18, 5. – P. 581–586. Doi:10.1053/j.jvca.2004.07.016.; Joannidis M., Kountchev J., Rauchenzauner M. et al. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study // Intensive Care Med. – 2007. – Vol. 33, № 9. – P. 1571–1579. Doi:10.1007/s00134-007-0719-7.; Kawazoe Y., Sato T., Miyagawa N. et al. Mortality effects of prolonged hemoperfusion therapy using a polymyxin b-immobilized fiber column for patients with septic shock: a sub-analysis of the DESIRE trial // Blood Purif. – 2018. – Vol. 46, № 4. – P. 309–314. Doi:10.1159/000491744.; Kellum J. A., Lameire N. KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) // Crit Care. – 2013. – Vol. 17, № 1. – P. 204. Doi:10.1186/cc11454.; Khadzhynov D., Dahlinger A., Schelter C. et al. Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation // Crit Care Med. – 2017. – Vol. 45 , № 9. – P. e941–e946. Doi:10.1097/CCM.0000000000002501.; Khadzhynov D., Schelter C., Lieker I. et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation // J Crit Care. – 2014. – Vol. 29, № 2. – P. 265–271. Doi:10.1016/j.jcrc.2013.10.015.; Klingele M., Stadler T., Fliser D. et al. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction // Crit Care. – 2017. – Vol. 21, № 1. – P. 294. Doi:10.1186/s13054-017-1870-3.; Kogelmann K., Hübner T., Schwameis F. et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of adjuvant cytosorb hemoadsorption therapy in patients with septic shock // J Clin Med. – 2021. – Vol. 10, № 13. – P. 2939. Doi:10.3390/jcm10132939.; Lazrak H. H., René É., Elftouh N. et al. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis // BMC Nephrol. – 2017. – Vol. 18, № 1. – P. 187. Doi:10.1186/s12882-017-0596-4.; Lee C. T., Chao A., Lai C. H. et al. Heparin dosing score protocol for anticoagulation during polymyxin B hemoperfusion // J Formos Med Assoc. – 2018. – Vol. 117, № 7. – P. 652–653. Doi:10.1016/j.jfma.2018.03.001.; Legrand M., Tolwani A. Anticoagulation strategies in continuous renal replacement therapy // Semin Dial. – 2021. – Vol. 34, № 6. – P. 416–422. Doi:10.1111/sdi.12959.; Levi M., Meijers J. C. DIC: which laboratory tests are most useful // Blood Rev. – 2011. – Vol. 25, № 1. – P. 33–37. Doi:10.1016/j.blre.2010.09.002.; Li X., Liu C., Mao Z. et al. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis // J Crit Care. – 2021. – Vol. 63. – P. 187–195. Doi:10.1016/j.jcrc.2020.09.007.; Li Z., Wang G., Zhen G. et al. Effects of hemodialysis combined with hemoperfusion on severe acute pancreatitis // Turk J Gastroenterol. – 2018. – Vol. 29, № 2. – P. 198–202. Doi:10.5152/tjg.2018.17415.; Lim W., Cook D. J., Crowther M. A. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials // J Am Soc Nephrol. – 2004. – Vol. 15, № 12. – P. 3192–3206. Doi:10.1097/01.ASN.0000145014.80714.35.; Liu C., Mao Z., Kang H. et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials // Crit Care. – 2016. – Vol. 20, № 1. – P. 144. Doi:10.1186/s13054-016-1299-0.; Mahieu E., Claes K., Jacquemin M. et al. Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation // Artif Organs. – 2013. – Vol. 37, № 5. – P. 482–487. Doi:10.1111/aor.12002.; Maurin N. Heparin resistance and antithrombin deficiency // Med Klin (Munich). – 2009. – Vol. 104, № 6. – P. 441–449. Doi:10.1007/s00063-009-1093-8.; Oudemans-van Straaten H. M., Kellum J. A., Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? // Crit Care. – 2011. – Vol. 15, № 1. – P. 202. Doi:10.1186/cc9358.; Panicucci F., Sagripanti A., Conte B. et al. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition // Haemostasis. – 1980. – Vol. 9, № 5. – P. 297–302. Doi:10.1159/000214368. PMID: 7409613.; Payen D. M., Guilhot J., Launey Y. et al. ABDOMIX Group. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial // Intensive Care Med. – 2015. – Vol. 41, № 6. – P. 975–984. Doi:10.1007/s00134-015-3751-z.; Ricci Z., Romagnoli S. Technical complications of continuous renal replacement therapy // Сontrib Тephrol. – 2018. – Vol. 194. – P. 99–108. Doi:10.1159/000485607.; Rugg C., Klose R., Hornung R. et al. Hemoadsorption with Cytosorb in septic shock reduces catecholamine requirements and in-hospital mortality: a single-center retrospective ‘genetic’ matched analysis // Biomedicines. – 2020. – Vol. 28, № 12. – P. 539. Doi:10.3390/biomedicines8120539.; Santoshi R. K., Patel R., Patel N. S. et al. Comprehensive review of thrombocytopenia with a spotlight on intensive care patients // Cureus. – 2022. – Vol. 14, № 8. – e27718. Doi:10.7759/cureus.27718.; Hoppensteadt D., Walenga J. M., Fareed J. et al. Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation // Hematol Oncol Clin North Am. – 2003. – Vol. 17, № 1. – P. 313–341. Doi:10.1016/s0889-8588(02)00091-6.; Schetz M. Anticoagulation in continuous renal replacement therapy // Contrib Nephrol. – 2001. – Vol. 132. – P. 283–303. Doi:10.1159/000060097.; Schilder L., Nurmohamed S. A., Bosch F. H. et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial // Crit Care. – 2014. – Vol. 18, № 4. – P. 472. Doi:10.1186/s13054-014-0472-6.; Schneider A. G., Journois D., Rimmelé T. Complications of regional citrate anticoagulation: accumulation or overload? // Crit Care. – 2017. – Vol. 21, № 1. – P. 281. Doi:10.1186/s13054-017-1880-1.; Schultheiß C., Saugel B., Phillip V. et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study // Crit Care. – 2012. – Vol. 16, № 4. – R162. Doi:10.1186/cc11485. PMID: 22913794; PMCID: PMC3580752.; Schwarzer P., Kuhn S.O., Stracke S. et al. Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation // Crit Care. – 2015. – Vol. 19, № 1. – P. 321. Doi:10.1186/s13054-015-1027-1.; Slowinski T., Morgera S., Joannidis M. et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study // Crit Care. – 2015. – Vol. 19. – P. 349. Doi:10.1186/s13054-015-1066-7.; Vincent J. L., Laterre P. F., Cohen J. et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection // Shock. – 2005. – Vol. 23, № 5. – P. 400-405. Doi:10.1097/01.shk.0000159930.87737.8a.; White D., MacDonald S., Bull T. et al. Heparin resistance in COVID-19 patients in the intensive care unit // J Thromb Thrombolysis. – 2020. – Vol. 50, № 2. – P. 287–291. Doi:10.1007/s11239-020-02145-0.; Young E., Podor T. J., Venner T. et al. Induction of the acute-phase reaction increases heparin-binding proteins in plasma // Arterioscler Thromb Vasc Biol. – 1997. – Vol. 17, № 8. – P. 1568–1574. Doi:10.1161/01.atv.17.8.1568.; Zhang W., Bai M., Yu Y. et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis // Crit Care. – 2019. – Vol. 23, № 1. – P. 22. Doi:10.1186/s13054-019-2317-9.
-
3Academic Journal
Συγγραφείς: R. V. Аkmalova, Yu. S. Polushin, D. V. Sokolov, I. V. Shlyk, E. V. Parshin, O. V. Galkina, Р. В. Акмалова, Ю. С. Полушин, Д. В. Соколов, И. В. Шлык, Е. В. Паршин, О. В. Галкина
Συνεισφορές: The authors express their deepest gratitude for the help in implementing the technology in practice to all employees of Intensive Care Unit № 4 for Emergency Detoxification of the Research Clinical Center of Anesthesiology and Intensive Care, Pavlov University, Авторский коллектив выражает благодарность за помощь в реализации технологии на практике всем сотрудникам отделения реанимации и интенсивной терапии № 4 для экстренной детоксикации Научно-клинического центра анестезиологии и реаниматологии Первого Санкт-Петербургского государственного университета им. акад. И. П. Павлова
Πηγή: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 20, № 3 (2023); 67-74 ; Вестник анестезиологии и реаниматологии; Том 20, № 3 (2023); 67-74 ; 2541-8653 ; 2078-5658
Θεματικοί όροι: продолжительная заместительная почечная терапия, thromboelastogram (TEG), fibrinogen, D-dimer, COVID-19, continuous renal replacement therapy (CRRT), тромбоэластограмма, фибриноген, D-димер
Περιγραφή αρχείου: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/817/641; Бахтиярова К. С., Папоян А. О., Алексеев А. В. и др. Ранние изменения клинико-лабораторных показателей у пациентов, умерших от COVID-19 // Вестник анестезиологии и реаниматологии. – 2022. – Т. 19, № 5. – С. 55–62. Doi:10.21292/2078-5658-2022-19-5-55-62.; Ладожская-Гапеенко Е. Е., Храпов К. Н., Полушин Ю. С., Шлык И. В., Вартанова И. В. и др. Оценка состояния микроциркуляции у больных с тяжелым течением COVID-19 методом капилляроскопии ногтевого ложа // Вестник анестезиологии и реаниматологии. ‒ 2021. ‒ Т. 18, № 1. ‒ C. 27–36. Doi:10.21292/2078-5658-2021-18-1-27-36.; Некрасова Л. А., Нестерова О. Ю., Самоходская Л. М., Семина Е. В., Камалов А. А. Взаимосвязь белков системы фибринолиза с тяжестью течения COVID-19. Обзор актуальных клинических данных и перспективных терапевтических стратегий // Кардиологический вестник. – 2022. – Т. 7, № 3. – С. 29–38. Doi:10.17116/Cardiobulletin20221703129.; Полушин Ю. С., Акмалова Р. В., Бовкун И. В., Соколов Д. В., Шлык И. В., Гаврилова Е. Г., Паршин Е. В. Острая дисфункция почек у больных новой коронавирусной инфекцией // Вестник анестезиологии и реаниматологии. ‒ 2021. – Т. – 18, № 3. – С. 7–14. Doi:10.21292/2078-5658-2021-18-3-7-14.; Полушин Ю. С., Акмалова Р. В., Соколов Д. В., Бовкун И. В., Гаврилова Е. Г. и др. Изменение уровня некоторых цитокинов при использовании гемофильтрации с сорбцией у пациентов с COVID-19 // Вестник анестезиологии и реаниматологии. ‒ 2021. – Т. – 18, № 2. – С. 31–39. Doi:10.21292/2078-5658-2021-18-2-31-39.; Самородов А. В., Золотухин К. Н., Заболотский Д. В., Александрович Ю. С., Баширова Л. И. Особенности тромбоэластографического профиля пациентов с COVID-19 в условиях ОРИТ // Вестник анестезиологии и реаниматологии. – 2020. – Т. 17, № 6. – С. 39–44. Doi:10.21292/2078-5658-2020-17-6-39-44.; Сироткина О. В., Улитина А. С., Кулабухова Д. Г. и др. Корреляция лабораторных маркеров активации системы гемостаза с концентрацией и размером внеклеточных микрочастиц плазмы крови у пациентов с COVID-19 // Ученые записки СПбГМУ им. акад. И. П. Павлова. – 2022. – Т. 29, № 1. – С. 28–36. Doi:10.24884/1607-4181-2022-29-1-28-36.; Biswas I., Khan G. A. Coagulation disorders in COVID-19: role of toll-like receptors // J Inflamm Res. – 2020. – Vol. 29, № 13. – P. 823–828. Doi:10.2147/JIR.S271768.; Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study // Lancet. ‒ 2020. ‒ № 395. ‒ Р. 507–513. Doi:10.1016/S0140-67362030211-7.; Lai C., Shih T., Ko W. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges // Int. J. Antimicrob. Agents. ‒ 2020. ‒ № 55. ‒ Р. 105924. Doi:10.1016/j.ijantimicag.2020.105924.; Lehmann A., Prosch H., Zehetmayer S., Gysan M. R. et al. Impact of persistent D-dimer elevation following recovery from COVID-19 // PLoS One. 2021. – Vol. 16, № 10. – e0258351. Doi:10.1371/journal.pone.0258351.; Levi M., Iba T. COVID-19 coagulopathy: is it disseminated intravascular coagulation? // Intern Emerg Med. – 2021. – Vol. 16, № 2. – P. 309–312. Doi:10.1007/s11739-020-02601-y.; Marvi T. K., Stubblefield W. B., Tillman B. F. et al. Serial thromboelastography and the development of venous thromboembolism in critically ill patients with COVID-19 // Crit Care Explor. – 2022. – Vol. 4, № 1. – e0618. Doi:10.1097/CCE.0000000000000618.; Nagashima S., Mendes M. C., Camargo Martins A. P. et al. Endothelial dysfunction and thrombosis in patients with COVID-19-brief report // Arterioscler Thromb Vasc Biol. – 2020. – Vol. 40, № 10. – P. 2404–2407. Doi:10.1161/ATVBAHA.120.314860.; Pine A. B., Meizlish M. L., Goshua G. et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19 // Pulmonary Circulation. – 2020. – Vol. 10, № 4. – 2045894020966547. Doi:10.1177/2045894020966547.; Rostami M., Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review // Expert Rev Hematol. – 2020. – Vol. 13, № 11. – P. 1265–1275. Doi:10.1080/17474086.2020.1831383.; Shankaralingappa A., Tummidi S., Arun Babu T. Diagnostic value of platelet indices in COVID 19 infection: a case-control study from a single tertiary care center // Egypt J Intern Med. – 2022. – Vol. 34, № 1. – P. 35. Doi:10.1186/s43162-022-00123-x.; Schutte T., Thijs A., Smulders Y. M. Never ignore extremely elevated D-dimer levels: they are specific for serious illness // Neth J Med. – 2016. – Vol. 74, № 10. – P. 443–448. PMID: 27966438.; Van der Poll T., de Jonge E., ten Cate an H. Cytokines as regulators of coagulation // Madame Curie Bioscience Database. – Austin (TX): Landes Bioscience. – 2000–2013. URL: www.ncbi.nlm.nih.gov/books/NBK6207.; Wright F. L., Vogler T. O., Moore E. E. et al. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 Infection // J. Am. Coll. Surg. ‒ 2020. ‒ Vol. 231, № 2. ‒ Р. 193–203. Doi:10.1016/j.jamcollsurg.2020.05.007.; Zuo Y., Warnock M., Harbaugh A. et al. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients // Sci Rep. – 2021. – Vol. 11. – P. 1580. Doi:10.1038/s41598-020-80010-z.
-
4Academic Journal
Συγγραφείς: E. N. Plakhotina, T. N. Belousova, N. B. Kuzina, A. N. Kuzovlev, E. V. Bryantsev, Е. Н. Плахотина, Т. Н. Белоусова, Н. Б. Кузина, А. Н. Кузовлев, Е. В. Брянцев
Συνεισφορές: The study has no sponsorship, Исследование не имеет спонсорской поддержки
Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 1 (2022); 12-21 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 1 (2022); 12-21 ; 2541-8017 ; 2223-9022
Θεματικοί όροι: эпидуральная гематома, neuraxial blockade, thromboelastogram, functional fibrinogen, epidural hematoma, нейроаксиальная блокада, тромбоэластограмма, функциональный фибриноген
Περιγραφή αρχείου: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/1335/1082; https://www.jnmp.ru/jour/article/view/1335/1129; Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017;131(21):2271–2277. https://doi.org/10.1182/blood-2017-05-781971. PMID: 28637667; Umazume T, Yamada T, Morikawa M, Ishikawa S, Furuta I, Koyama T, et al. Platelet reactivity in twin pregnancies. Thromb Res. 2016;138:43–48. PMID: 26826507 https://doi.org/10.1016/j.thromres.2015.12.019; Kasai J, Aoki S, Kamiya N, Hasegawa Y, Kurasawa K, Takahashi T, et al. Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy. J Obstet Gynaecol. 2014;41(1):44–49. PMID: 25163390 https://doi.org/10.1111/jog.12496; Asif N, Hassan K. Thrombocytopenia in Pregnancy. Hematol Transfus Int J. 2017;5(5):307–309. https://doi.org/10.15406/htij.2017.05.00133; Fogerty A.E. Thrombocytopenia in pregnancy: mechanisms and management. Transfus Med Rev. 2018;32(4):225–229. PMID: 30177431 https://doi.org/10.1016/j.tmrv.2018.08.004; Грандоне Э., Мингалимов М.А., Григорьева К.Н., Бицадзе В.О., Шкода А.С., Хизроева Д.Х. и др. Тромбоцитопенические синдромы во время беременности. Акушерство и гинекология. 2019;(10):5–12. https://doi.org/10.18565/aig.2019.10.5-12; Palta A, Dhiman P. Thrombocytopenia in pregnancy. J Obstet Gynaecol. 2016;36(2):146–52. PMID: 26431056. https://doi.org/10.3109/01443615.2015.1041893; Куликова А.В., Шифман Е.М., Сокологорский С.В., Левит А.Л., Недашковский Э.В., Заболотских И.Б. и др. Нейроаксиальные методы обезболивания родов. Клиничекие рекомендации. Протоколы лечения. В кн.: Куликов А.В., Шифман Е.М. (ред.). Анестезиология, интенсивная терапия и реанимация в акушерстве и гинекологии. Клинические рекомендации. Протоколы лечения. Москва: Медицина; 2017. с.153-169. https://doi.org/10.18821/9785225100384; Lagerkranser M. Review Neuraxial blocks and spinal haematoma: Review of 166 case re-portspublished 1994–2015. Part 1: Demographics and risk-factors. Scand J Pain. 2017;15:118–129. PMID: 28850335 https://doi.org/10.1016/j.sjpain.2016.11.008; Lagerkranser M., Lindquist Сh. Neuraxial blocks and spinal haematoma: Review of 166 cas-espublished 1994–2015. Part 2: diagnosis, treatment, and outcome. Scand J Pain. 2017;15(1):130–136. PMID: 28850336 https://doi.org/10.1016/j.sjpain.2016.11.009; Bateman BT, Mhyre JM, Ehrenfeld J, Kheterpal S, Abbey KR, Argalious M, et al. The Risk and Outcomes of Epidural Hematomas After Perioperative and Obstetric Epidural Catheterization: A Report from the Multicenter Perioperative. Anesth Analg. 2013;116(6):1380–1385. PMID: 22504213 https://doi.org/10.1213/ANE.0b013e318251daed; Gulur P., Tsui B., Pathak R., Koury K.M., Lee H. Retrospective analysis of the incidence of epiduralhaematoma in patients with epidural catheters and abnormal coagulation parameters. Br J Anaesth. 2015;114(5):808–811. PMID: 25614136 https://doi.org/10.1093/bja/aeu461; Ehrenfeld JM, Agarwal AK, Henneman JP, Sandberg WS. Estimating the Incidence of Suspect-ed Epidural Hematoma and the Hidden Imaging Cost of Epidural Catheterization: A Retrospective Review of 43,200 Cases. Reg Anesth Pain Med. 2013;38(5):409–414. PMID: 23924685 https://doi.org/10.1097/AAP.0b013e31829ecfa6; Pitkänen MT, Aromaa U, Cozanitis DA, Förster JG. Serious complications associated with spi-nal and epidural anaesthesia in Finland from 2000 to 2009. Acta Anaesthesiol Scand. 2013;57:553–564. PMID: 23305109 https://doi.org/10.1111/aas.12064; Van Veen JJ, Nokes TJ, Makris M. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol. 2010;148(1):15–25. PMID: 19775301 https://doi.org/10.1111/j.1365-2141.2009.07899.; Cuypers V, Van de Velde M, Devroe S. Intracranial subdural haematoma following neuraxial anaesthesia in the obstetric population: a literature review with analysis of 56 reported cases. Int J Obstet Anesth. 2016;25:58–65. PMID: 26597409 https://doi.org/10.1016/j.ijoa.2015.09.003; Goodier CG, Lu JT, Hebbar L, Segal BS, Goetzl L. Neuraxial Anesthesia in Parturients with Thrombocytopenia: A Multisite Retrospective Cohort Study. Anesth Analg. 2015;121(4):988–991. PMID: 26378701 https://doi.org/10.1213/ANE.0000000000000882; Ruppen W, Derry S, McQuay H, Moore RA. Incidence of Epidural Hematoma, Infection, and Neurologic Injury in Obstetric Patients with Epidural Analgesia/Anesthesia. Anesthesiology. 2006;105(2):394–399. PMID: 16871074 https://doi.org/10.1097/00000542-200608000-00023; D’Angelo R, Smiley RM, Riley ET, Segal S. Serious Complications Related to Obstetric An-esthesia The Serious Complication Repository Project of the Society for Obstetric Anesthesia and Perinatology. Anesthesiology. 2014;120(6):1505–1512. PMID: 24845921 https://doi.org/10.1097/ALN.0000000000000253; Bernstein J, Hua B, Kahana M, Shaparin N, Yu S, Davila-Velazquez J. Neuraxial Anesthesia in Parturients with Low Platelet Counts. Anesth Analg. 2016;123(1):165–167. PMID: 27159067 https://doi.org/10.1213/ANE.0000000000001312; Tanaka M, Balki M, McLeod A, Carvalho JCA. Anestesia Regional e Trombocitopenia Não Pré-Eclâmptica; Hora de Repensar o Nível Seguro de Plaquetas. Revista Brasileira de Anestesiologia. 2009;59(2):142–153. PMID: 19488526 https://doi.org/10.1590/S0034-70942009000200002; Ray N. P. Can We Continue to Deny Neuraxial Anesthesia to Otherwise-Healthy Parturients With Thrombocytopenia? Anesth Analg. 2017;124(2):704–705. PMID: 28098703 https://doi.org/10.1213/ANE.0000000000001785; Bergmann F, Rath W. The Differential Diagnosis of Thrombocytopenia in Pregnancy. Dtsch Arztebl Int. 2015;112(47):795–802. PMID: 26634939 https://doi.org/10.3238/arztebl.2015.0795; Wang X, Xu Y, Luo W, Feng H, Luo Y, Wang Y, et al. Thrombocytopenia in pregnancy with different diagnoses Differential clinical features, treatments, and outcomes. Medicine (Baltimore). 2017;96(29):e7561. PMID: 28723784 https://doi.org/10.1097/MD.0000000000007561; Camann W. Obstetric Neuraxial Anesthesia Contraindicated? Really? Time to Rethink Old Dogma. Anesth Analg. 2015;121(4):846–848. PMID: 26378695 https://doi.org/10.1213/ANE.0000000000000925; Lee LO, Bateman BT, Kheterpal S, Klumpner TT, Housey M, Aziz MF, et al. Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients. A Report from the Multi-center Perioperative Outcomes Group. Anesthesiology. 2017;126(6):1053–1064. PMID: 28383323 https://doi.org/10.1097/ALN.0000000000001630; Orlikowski CE, Rocke DA, Murray WB, Gouws E, Moodley J, Kenoyer DG, et al. Thrombelas-tography changes in pre-eclampsia and eclampsia. Br J Anaesth. 1996;77(2):157–161. PMID: 8881617 https://doi.org/10.1093/bja/77.2.157; Huang J, McKenna N, Babins N. Utility of Thromboelastography During Neuraxial Blockade in the Parturient with Thrombocytopenia. AANA J. 2014;82(2):127–130. PMID: 24902455; Katz D, Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth. 2015;115(2):75–88. PMID: 26658204 https://doi.org/10.1093/bja/aev374; Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379:32–43. https://doi.org/10.1056/NEJMoa1802897; https://www.jnmp.ru/jour/article/view/1335
-
5Academic Journal
Συγγραφείς: A. Amendola, G. Paternoster, S. P Pascale, R. Nuccorini, M. D'Amora, G. Pittella, R. D'Ascoli, F. Prestipino, G. Luzi, M. Pizzuti, А. Амендола, Дж. Патерностер, С. П. Паскале, Р. Нуккорини, М. Д'Амора, Дж. Питтелла, Р. Д'Асколи, Ф. Престипино, Дж. Луци, М. Пиццути
Πηγή: General Reanimatology; Том 17, № 2 (2021); 27-36 ; Общая реаниматология; Том 17, № 2 (2021); 27-36 ; 2411-7110 ; 1813-9779
Θεματικοί όροι: тромбоэластограмма, eculizumab, thromboelastogram, экулизумаб
Περιγραφή αρχείου: application/pdf
Relation: https://www.reanimatology.com/rmt/article/view/2050/1496; https://www.reanimatology.com/rmt/article/view/2050/1497; Brodsky R.A. Paroxysmal nocturnal hemoglobinuria. Blood. 2014: 30; 124 (18): 2804-2811. PMID: 25237200 PMCID: PMC4215311. DOI:10.1182/blood-2014-02-522128; Schrezenmeier H., Muus P, Socie G., Szer J., Urbano-Ispizua A., Ma-ciejewski J.P., Brodsky R.A., Bessler M., Kanakura Y., Wendell Rosse W., Khursigara G., Bedrosian C., Hillmen P. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014; 99 (5): 922-929. PMID: 24488565 PMCID: PMC4008114. DOI:10.3324/haematol.2013.093161; Lima M. Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. Pract Lab Med. 2020; 20: e00158. PMID: 32195308 PMCID: PMC7078534. DOI:10.1016/j.plabm.2020.e00158; Socie G., Varoqueaux N., Peffault de Latour R. Eculizumab in Paroxysmal nocturnal hemoglobinuria. Med Sci (Paris). 2009; 25 (12): 126-9. PMID: 20035691. DOI:10.1051/medsci/200925121126; Griffin M., Munir T. Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. Ther Adv Hematol. 2017; 8 (3): 119-126. PMID: 28246555 PMCID: PMC5305005. DOI:10.1177/2040620716681748; Kang K.-W., Moon H., Lee B.-H., Jeon M.-J., Yu E.S., Kim D.-S., Lee S.-R., Sung H.-J., Choi C.-W., Kim B.-S., Lee J.-Y., Park Y. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab. Ann Hematol. 2020; 99 (7): 1493-1503. PMID: 32542443. DOI:10.1007/s00277-020-04133-z; Röth A., Araten D.J., Larratt L., Kulasekararaj A.J., Maciejewski J.P., Wilson A., Gustovic P., Kanakura Y. Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry. Eur J Haematol. 2020; 105 (5): 561–570. PMID: 32640047. DOI:10.1111/ejh.13485; Villegas A., Arrizabalaga B., Bonanad S., Colado E., Gaya A.M., Ataúlfo González F., Jarque I., Núñez R., Ojeda E., Orfao A., Ribera Santasusana J.M., Ortega V.V., Ispizua A.U. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 2016; 146 (6): 278.e1–278.e7. DOI:10.1016/j.medcli.2015.12.012; Cançado R.D., Araújo A da S., Sandes A.F., Arrais C., Lopes De Castro Lobo C., Figueiredo M.S., Menosi Gualandro S.F., Olalla Saad S.T., Ferreira Costa F. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematology, Transfusion and Cell Therapy. Published online July 2020: S2531137920300791. DOI:10.1016/j.htct.2020.06.006; van Bijnen S.T.A., Vermeer H., Mourisse J.M.J., de Witte T., van Swieten H.A., Muus P. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab: Letter to the Editor. European Journal of Haematology. 2011; 87 (4): 376–378. PMID: 21623921. DOI:10.1111/j.16000609.2011.01656.x; Pape L., Hartmann H., Bange F.C., Suerbaum S., Bueltmann E., Ahlenstiel-Grunow T. Eculizumab in typical hemolytic uremic syndrome (Hus) with neurological involvement. Medicine. 2015; 94 (24): e1000. PMID: 26091445 PMCID: PMC4616562. DOI:10.1097/MD.0000000000001000; Gross O. Eculizumab end ECMO rescue therapy of most severe ARDS in a young boy with goodpasture's syndrome. In: Proceedings from ASN Kidney Week. New Orleans, LA; 2017: A THPO439; Neumann F-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.-P, Falk V, Head S.J., Juni P, Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O., ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal. 2019; 40 (2): 87-165. PMID: 30165437. DOI:10.1093/eurheartj/ehy394; Patel M.R., Dehmer G.J., Grantham J.A., Maddox T.M., Maron D.J., Smith P.K. Calhoon J.H., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. Journal of the American College of Cardiology. 2017; 69 (17): 2212-2241. PMID: 28291663. DOI:10.1016/j.jacc.2017.02.001; Mannacio V., Di Tommaso L., De Amicis V., Stassano P., Vosa C. Randomized flow capacity comparison of skeletonized and pedicled left internal mammary artery. The Annals of Thoracic Surgery. 2011; 91 (1): 24–30. PMID: 21172479. DOI:10.1016/j.athoracsur.2010.06.131; Guru V. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006; 114 (1_suppl): I-331I-338. PMID: 16820596. DOI:10.1161/CIRCULATIONAHA.105.001644; Raja S.G. Surgical strategies for bilateral internal mammary artery grafting. International Journal of Surgery. 2015; 16: 140–145. PMID: 25463040. DOI:10.1016/j.ijsu.2014.11.006; Dias J.D., Sauaia A., Achneck H.E., Hartmann J., Moore E.E. Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost. 2019; 17 (6): 984–994. PMID: 30947389 PMCID: PMC6852204. DOI:10.1111/jth.14447; Nakayama Y., Nakajima Y., Tanaka K.A., Sessler D.I., Maeda S., Iida J., Ogawa S., Mizobe T. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015; 114 (1): 91–102. PMID: 25303988. DOI:10.1093/bja/aeu339; https://www.reanimatology.com/rmt/article/view/2050
-
6Academic Journal
Πηγή: Тромбоз, гемостаз и реология.
Θεματικοί όροι: система гемостаза, ишемический инсульт, прогнозирование, reocclusion, тромбоэластограмма, ischemic stroke, hemostasis, prognosis, 3. Good health, реокклюзия, thromboelastogram
Σύνδεσμος πρόσβασης: http://thrj.ru/index.php/thrj/article/view/136
-
7Academic Journal
Συγγραφείς: A. L. Mishchenko, N. M. Khamani, N. S. Stuleva, А. Л. Мищенко, Н. М. Хамани, Н. С. Стулёва
Πηγή: Obstetrics, Gynecology and Reproduction; Vol 10, No 1 (2016); 62-73 ; Акушерство, Гинекология и Репродукция; Vol 10, No 1 (2016); 62-73 ; 2500-3194 ; 2313-7347 ; 10.17749/2313-7347.2016.10.1
Θεματικοί όροι: коагулопатия, infants, coagulometers, platelets, thromboelastogramm, coagulopathy, новорожденные, коагулометры, тромбоциты, тромбоэластограмма
Περιγραφή αρχείου: application/pdf
Relation: https://www.gynecology.su/jour/article/view/36/526; Макацария А.Д., Червенак Ф.А., Бицадзе В.О. Беременность высокого риска. М. 2015; 203, 476, 581-593, 890, 895, 903.; Макацария А.Д., Бицадзе В.О., Акиньшина С.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. М. 2007; 738, 755, 918.; Cohen H., O’Brien P. Disorders of Thrombosis and Hemostasis in pregnancy. A guide to management. 2012; 115, 219.; ISTH Advanced Training course in Thrombosis and hemostasis. September 14-17, 2015. Dubai, UAE. S7, S18.; Francis C., Sandset P.M. Thrombosis research. Official journal of the European Thrombosis Research Organization. January 2013; 131 (1): 28.; Francis C., Sandset P.M. Thrombosis research. Official journal of the European Thrombosis Research Organization. February 2015; 135 (1): 34, 41.; Studd J., Lin Tan S., Chervenak F.A. Current progress in obstetrics and gynaecology. 2014; 2: 110, 199.; Weber C., Gregory Y. Inernational journal for vascular biology and medicine. Thrombosis and haemostasis. November 2015; 114 (5): 883; https://www.gynecology.su/jour/article/view/36
-
8Academic Journal
Συγγραφείς: Makarenko, M. V., Govsieiev, D. A., Sokol, I. V., Slobodenyuk, A. I., Berestovoy, V. O., Vorona, R. M.
Πηγή: Перинатологія і педіатрія; № 3(71) (2017): Перинатологія та педіатрія; 39-43
Перинатология и педиатрия; № 3(71) (2017): Перинатология и педиатрия; 39-43
Perinatologiya i pediatriya; № 3(71) (2017): Perinatologiya i pediatriya; 39-43Θεματικοί όροι: тромбоэластография, тромбоэластограмма, акушерское кровотечение, тромбоцитопения, гемостаз, тромбоеластографія, тромбоеластограма, акушерська кровотеча, тромбоцитопенія, 3. Good health, thromboelastography, obstetric hemorrhage, thrombocytopenia, hemostasis
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://pip.med-expert.com.ua/article/view/PP.2017.71.39
-
9Academic Journal
Συγγραφείς: Кузьменко, Галина, Назаров, Сергей, Попова, Ирина, Клычева, Майя, Харламова, Наталья, Малышкина, Анна
Θεματικοί όροι: НОВОРОЖДЕННЫЕ, ГЛУБОКО НЕДОНОШЕННЫЕ НОВОРОЖДЕННЫЕ, НОВОРОЖДЕННЫЕ С ЭКСТРЕМАЛЬНО НИЗКОЙ МАССОЙ ТЕЛА, ГЕМОСТАТИЧЕСКИЙ ПОТЕНЦИАЛ КРОВИ, ТРОМБОЭЛАСТОГРАММА
Περιγραφή αρχείου: text/html
-
10Academic Journal
Πηγή: Российский педиатрический журнал.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, 3. Good health, НОВОРОЖДЕННЫЕ, ГЛУБОКО НЕДОНОШЕННЫЕ НОВОРОЖДЕННЫЕ, НОВОРОЖДЕННЫЕ С ЭКСТРЕМАЛЬНО НИЗКОЙ МАССОЙ ТЕЛА, ГЕМОСТАТИЧЕСКИЙ ПОТЕНЦИАЛ КРОВИ, ТРОМБОЭЛАСТОГРАММА
Περιγραφή αρχείου: text/html
-
11Academic Journal
Πηγή: Российский медицинский журнал.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, СЕПСИС, СИНДРОМ СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ, ПОСЛЕРОДОВЫЙ ПЕРИОД, ТРОМБОЭЛАСТОГРАММА, 3. Good health
Περιγραφή αρχείου: text/html
-
12
-
13Electronic Resource
Additional Titles: Аортокоронарное шунтирование у пациента с пароксизмальной ночной гемоглобинурией (клиническое наблюдение)
Συγγραφείς: A. Amendola ; Hematology and HSC Transplant Center, G. Paternoster ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, S. Pascale P; Hematology and HSC Transplant Center, R. Nuccorini ; Hematology and HSC Transplant Center, M. D'Amora ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, G. Pittella ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, R. D'Ascoli ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, F. Prestipino ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, G. Luzi ; Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo, M. Pizzuti ; Hematology and HSC Transplant Center, А. Амендола ; Центр гематологии и трансплантации гемопоэтических стволовых клеток, Дж. Патерностер ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, С. Паскале П.; Центр гематологии и трансплантации гемопоэтических стволовых клеток, Р. Нуккорини ; Центр гематологии и трансплантации гемопоэтических стволовых клеток, М. Д'Амора ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, Дж. Питтелла ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, Р. Д'Асколи ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, Ф. Престипино ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, Дж. Луци ; Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии, М. Пиццути ; Центр гематологии и трансплантации гемопоэтических стволовых клеток
Πηγή: General Reanimatology; Том 17, № 2 (2021); 27-36; Общая реаниматология; Том 17, № 2 (2021); 27-36; 2411-7110; 1813-9779
Όροι ευρετηρίου: paroxysmal nocturnal haemoglobinuria; eculizumab; thromboelastogram, пароксизмальная ночная гемоглобинурия; экулизумаб; тромбоэластограмма, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
Σύνδεσμος:
https://www.reanimatology.com/rmt/article/view/2050/1496 https://www.reanimatology.com/rmt/article/view/2050/1497 https://www.reanimatology.com/rmt/article/view/2050/1496 https://www.reanimatology.com/rmt/article/view/2050/1497
Brodsky R.A. Paroxysmal nocturnal hemoglobinuria. Blood. 2014: 30; 124 (18): 2804-2811. PMID: 25237200 PMCID: PMC4215311. DOI: 10.1182/blood-2014-02-522128
Schrezenmeier H., Muus P, Socie G., Szer J., Urbano-Ispizua A., Ma-ciejewski J.P., Brodsky R.A., Bessler M., Kanakura Y., Wendell Rosse W., Khursigara G., Bedrosian C., Hillmen P. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014; 99 (5): 922-929. PMID: 24488565 PMCID: PMC4008114. DOI: 10.3324/haematol.2013.093161
Lima M. Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. Pract Lab Med. 2020; 20: e00158. PMID: 32195308 PMCID: PMC7078534. DOI: 10.1016/j.plabm.2020.e00158
Socie G., Varoqueaux N., Peffault de Latour R. Eculizumab in Paroxysmal nocturnal hemoglobinuria. Med Sci (Paris). 2009; 25 (12): 126-9. PMID: 20035691. DOI: 10.1051/medsci/200925121126
Griffin M., Munir T. Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. Ther Adv Hematol. 2017; 8 (3): 119-126. PMID: 28246555 PMCID: PMC5305005. DOI: 10.1177/2040620716681748
Kang K.-W., Moon H., Lee B.-H., Jeon M.-J., Yu E.S., Kim D.-S., Lee S.-R., Sung H.-J., Choi C.-W., Kim B.-S., Lee J.-Y., Park Y. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab. Ann Hematol. 2020; 99 (7): 1493-1503. PMID: 32542443. DOI: 10.1007/s00277-020-04133-z
Röth A., Araten D.J., Larratt L., Kulasekararaj A.J., Maciejewski J.P., Wilson A., Gustovic P., Kanakura Y. Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry. Eur J Haematol. 2020; 105 (5): 561–570. PMID: 32640047. DOI: 10.1111/ejh.13485
Villegas A., Arrizabalaga B., Bonanad S., Colado E., Gaya A.M., Ataúlfo González F., Jarque I., Núñez R., Ojeda E., Orfao A., Ribera Santasusana J.M., Ortega V.V., Ispizua A.U. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 2016; 146 (6): 278.e1–278.e7. DOI: 10.1016/j.medcli.2015.12.012
Cançado R.D., Araújo A da S., Sandes A.F., Arrais C., Lopes De Castro Lobo C., Figueiredo M.S., Menosi Gualandro S.F., Olalla Saad S.T., Ferreira Costa F. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematology, Transfusion and Cell Therapy. Published online July 2020: S2531137920300791. DOI: 10.1016/j.htct.2020.06.006
van Bijnen S.T.A., Vermeer H., Mourisse J.M.J., de Witte T., van Swieten H.A., Muus P. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab: Letter to the Editor. European Journal of Haematology. 2011; 87 (4): 376–378. PMID: 21623921. DOI: 10.1111/j.16000609.2011.01656.x
Pape L., Hartmann H., Bange F.C., Suerbaum S., Bueltmann E., Ahlenstiel-Grunow T. Eculizumab in typical hemolytic uremic syndrome (Hus) with neurological involvement. Medicine. 2015; 94 (24): e1000. PMID: 26091445 PMCID: PMC4616562. DOI: 10.1097/MD.0000000000001000
Gross O. Eculizumab end ECMO rescue therapy of most severe ARDS in a young boy with goodpasture's syndrome. In: Proceedings from ASN Kidney Week. New Orleans, LA; 2017: A THPO439
Neumann F-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.-P, Falk V, Head S.J., Juni P, Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O., ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal. 2019; 40 (2): 87-165. PMID: 30165437. DOI: 10.1093/eurheartj/ehy394
Patel M.R., Dehmer G.J., Grantham J.A., Maddox T.M., Maron D.J., Smith P.K. Calhoon J.H., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. Journal of the American College of Cardiology. 2017; 69 (17): 2212-2241. PMID: 28291663. DOI: 10.1016/j.jacc.2017.02.001
Mannacio V., Di Tommaso L., De Amicis V., Stassano P., Vosa C. Randomized flow capacity comparison of skeletonized and pedicled left internal mammary artery. The Annals of Thoracic Surgery. 2011; 91 (1): 24–30. PMID: 21172479. DOI: 10.1016/j.athoracsur.2010.06.131
Guru V. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006; 114 (1_suppl): I-331I-338. PMID: 16820596. DOI: 10.1161/CIRCULATIONAHA.105.001644
Raja S.G. Surgical strategies for bilateral internal mammary artery grafting. International Journal of Surgery. 2015; 16: 140–145. PMID: 25463040. DOI: 10.1016/j.ijsu.2014.11.006
Dias J.D., Sauaia A., Achneck H.E., Hartmann J., Moore E.E. Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost. 2019; 17 (6): 984–994. PMID: 30947389 PMCID: PMC6852204. DOI: 10.1111/jth.14447
Nakayama Y., Nakajima Y., Tanaka K.A., Sessler D.I., Maeda S., Iida J., Ogawa S., Mizobe T. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015; 114 (1): 91–102. PMID: 25303988. DOI: 10.1093/bja/aeu339
